Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO RE48389
SERIAL NO

15697146

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antibody drug conjugates (ADC's) that bind to 191P4D12 protein and variants thereof are described herein. 191P4D12 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SEAGEN INC21823 30TH DR SE BOTHELL WA 98021

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
An, Zili Los Angeles, US 23 118
Gudas, Jean Los Angeles, US 50 659
Jakobovits, Aya Beverly Hills, US 288 8747
Morrison, Karen Jane Meyrick Santa Monica, US 90 604
Morrison, Robert Kendall Santa Monica, US 90 568
Satpayev, Daulet Santa Monica, US 12 74
Torgov, Michael Santa Monica, US 53 594

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 12, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 12, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00